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Abstract 
Research into COVID-19 susceptibility and outcomes are critical, but claims must be 
carefully evaluated to inform policy decisions. In a recent series of articles, Manning and 
Fink (1–3) use national-level data to describe associations between case-fatality ratios and 
male and female finger ratios (2D:4D), a suggested measure of prenatal androgen exposure, 
as well as angiotensin-converting enzyme (ACE) allele and genotype frequencies. The 
authors suggest that 2D:4D is linked with ACE variant prevalence, and that higher male 
2D:4D is associated with higher case fatality ratios, and point to 2D:4D as a useful prognostic 
measure for COVID-19 susceptibility. A critical review and robust Bayesian analysis of the 
hypothesis is described here, finding no conclusive evidence of COVID-19 mortality and 
2D:4D, nor associations between 2D:4D and ACE1 allele or ACE2 genotype frequency. This 
absence of evidence is present for data taken from the second wave of COVID-19 in October 
2020. Problematic theoretical grounding, individual-level conclusions drawn from national-
level data, and issues with statistical inference in the original articles are discussed. Taken 
together, the current data offer no clear utility of 2D:4D in determining COVID-19 outcomes. 
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COVID-19 is a public health emergency, with researchers across broad disciplines 
contributing reports that progress understanding of disease susceptibility and progression. A 
clinical feature of the infection is that males experience more severe symptoms, and have 
higher mortality than females (4), consistent with other acute respiratory infections (5). While 
there is currently little supporting data, it has been suggested that androgen sensitivity 
facilitates more severe infection through greater levels of transmembrane protease serine 2 
(TMPRSS2; Wambier et al., 2020), and accordingly, males with more severe COVID-19 
infections present with phenotypes of high levels of androgen sensitivity, such as male 
pattern baldness (7). Related, angiotensin converting enzyme 2 (ACE2) has greater activity in 
males (8), and in other coronaviruses, has been shown to provide an entry point to the cell 
through cleaving with TMPRSS2 (9). ACE2 also has a fundamental role in COVID-19 
severity, acting as the main binding of the virus to cell surfaces (10), and its depletion leaves 
angiotensin II to damage cells (11). 
In a recent series of articles, Manning and Fink report the association of national-level 
index to ring finger ratio (2D:4D) with national case fatality rates (1–3), and test the 
associations of national-level ACE1 allele frequency and the ACE2 genotype on the same 
outcome (3). 2D:4D has long been thought to correlate negatively with prenatal androgen 
exposure, such that shorter index fingers relative to ring fingers indicate more prenatal 
androgen exposure (12). However, interestingly Manning and Fink report that countries with 
higher male 2D:4D ratios actually have higher case fatality ratios, suggesting that higher 
levels of prenatal testosterone may confer protection from COVID-19 symptoms (2,3). 
Manning and Fink suggest that this may be due to the frequency of the ACE2 genotype 
within a nation, higher levels of which reduce COVID-19 severity, while also demonstrating 
negative correlations between national level ACE1 allele frequency and ACE2 genotype 
frequency and national level 2D:4D (3), which are both thought to relate to androgen 
exposure (6,12). 
Taken together, the current evidence is used to suggest that 2D:4D could be used as a 
prognostic device for the severity of COVID-19 (1), or inform whom should engage in more 
stringent forms of social distancing (1). While this is an intriguing hypothesis, we outline 
below reasons why the existing evidence for it is weak.  
2D:4D as a marker of prenatal testosterone 
The hypothesis that 2D:4D is associated with COVID-19 outcomes rests on the 
assumption that 2D:4D is a valid measure of prenatal androgen exposure. In recent years, 
accumulating evidence has suggested that this relationship may not be robust. Both Hollier et 
al. (13) and Hickey et al (14) demonstrate no relationships between adult 2D:4D ratio and 
androgen concentrations in umbilical cord blood, providing a critical test of the prenatal 
androgen exposure hypothesis. There is also a lack of association between testosterone levels 
in amniotic fluid or mother’s plasma and 2D:4D, at least in infants (15). In addition, the 
association between human androgen receptor genes and 2D:4D are almost exactly null (16), 
as well as the association between circulating testosterone and continuous 2D:4D measures 
(17,18), and changes in testosterone and physical exercise (19), all of which suggests the 
basic biological mechanisms underpinning 2D:4D as a measure of any kind of testosterone 
exposure are weak to non-existent. In response to a similar criticism by Jones et al, (20) 
Manning and Fink (2) point out that 2D:4D shows associations with prenatal androgen 
exposure in discussions of sexual orientation (21) and gender dysphoria (22), but the direct 
evidence that higher levels of prenatal androgen impact later outcomes is missing. However, 
others demonstrate that 2D:4D is associated with amniotic fluid testosterone, but only in 
limited cases, such as for the left hands of females only (23), which makes its association 
with more severe COVID-19 for males difficult to reconcile. 
However, the relationships between 2D:4D and physical endurance and performance 
offer some theoretical grounding for the relationship between COVID-19 outcomes and digit 
ratio, in that lung capacity and efficiency may be linked to testosterone exposure. For 
example, male rowers with lower 2D:4D show faster rowing times (24), and those with lower 
digit ratios record faster running times in endurance running competitions (25). These 
relationships are generally strong, but vary in their estimated strength in males (26,27), and 
are either present (27,28) or absent in females (25,29). 2D:4D of either hand is not associated 
with VO2 max, a measure of maximal oxygen uptake but the differences between the two 
hands may be (30), though this difference is not investigated frequently elsewhere. While 
equivocal, these findings do suggest a stronger link with 2D:4D and aspects of cardiovascular 
functioning. 
The ecological fallacy 
A concerning aspect of the hypothesis suggested by Manning and Fink is that it is 
based solely on national-level data. Manning and Fink use aggregated country-level 2D:4D 
measures taken from the BBC internet study, which comprises of thousands of self-reported 
digit measurements from around the world (31). These are then related to country-level case 
fatality ratios. While there is nothing inherently incorrect with analysing aggregate-level data 
(sometimes referred to as ecological correlations (32), and in some cases they yield the same 
conclusions as individual-level data, this analytical approach becomes problematic when 
inferences are extended to the individual level, and assuming the relationships are the same at 
both levels is misleading (33). In this case, Manning and Fink infer many individual-level 
conclusions from their data, such as suggesting that an individual’s ACE2 genotype will 
influence 2D:4D (3), and recommendations of who should social distance based on digit 
ratios (1). In both recent articles, findings are framed heavily in terms of the relationships 
between hormonal and genetic pathways, which occur within individuals, which the data has 
no bearing on. While trait relationships with 2D:4D have been shown to exist at national and 
individual levels, such as in the case of alcohol and cigarette consumption (34), the default 
position should not assume this duality is consistent, particularly in the context of a public 
health crisis, especially when the absence of such a duality is a significant problem in 
inference (33). 
Statistical Inference 
All claims rest on the robustness of the statistical inferences made, and there are 
several issues with the analyses presented in the recent series of articles suggesting links 
between COVID-19 and digit ratio (1–3). There are four issues in particular. The first is that 
the outcome measure of case fatality ratio (the number of deaths divided by the number of 
cases) is likely a biased measure, given that each nation my record cases differently – for 
example, either by recording all confirmed cases, or by reporting only cases where death or 
recovery has occurred, which means a ratio of deaths to cases will be biased in some way 
(35). In addition, there may be time-lags in how cases are reported within a nation, which is 
especially true during the early stages of the pandemic, upon which the initial findings were 
reported (1), which means the measure is likely noisy. It is also worth noting that the World 
Health Organisation reports give cumulative death rates and cumulative cases, which are used 
to define the case fatality rate, which are more closely aligned to a measure of a proportion of 
a group that die over a specific time, rather than a case fatality rate (35) 
Second, there is an overreliance on simple bivariate correlations for the various 
combinations of male, female, left and right hands, and ACE1 and ACE2 frequencies, and 
case fatality ratios as defined in the articles. This approach greatly increases the likelihood of 
finding a statistically significant result when there is no relationship, due to false positive 
rates (36,37), which there are no multiple comparisons for. This is particularly concerning for 
right and left 2D:4D, as even though there are arguments to be made that these two variables 
are not simply a bilateral version of the same trait, but are affected differently by androgen 
exposure (38), there are no specific hypothesis tests regarding left or right hands in any of the 
existing articles (1,1,3) and conclusions are drawn directly about 2D:4D and its relationship 
with COVID-19 outcomes at a general level. Thus, corrections for multiple comparisons 
should be made for at least this aspect of the data. To compound this, the sample size is 
relatively small, though this is understandable given the nature of the dataset. Nonetheless, 
correlations are unstable in small samples where any outliers can sufficiently skew the 
estimated relationship higher to find a significant effect (39,40). 
Most concerning is that there is a dichotomous approach to inference (41) - effects are 
described as either present or absent, with an exclusive focus on p-values of regression or 
correlation coefficients. This is often misleading and can obscure what the models actually 
imply about the relationship between 2D:4D, ACE and COVID-19 outcomes (42). 
Interpretation and dissection of statistical models are essential to understand the credibility 
and plausibility of results, at a time when replication and reliability are low (43) and global 
pandemics demand reliable results (44). Crucially, the regression models described by 
Manning and Fink imply unrealistically large effects between digit ratio and expected 
mortality from COVID-19, which questions the credibility of the results. Sahin (45) offers an 
improved parameterisation of the models that more closely approximates the question, but the 
focus is once more on statistical significance, and includes unjustified covariates to improve 
model fits.  
As an example, Manning and Fink (1) report a multiple regression model predicting 
log case fatality ratio from national right-hand 2D:4Ds of males and females. The male 
coefficient is significant; B = 51.84, p = .025, while for females it is not; B = -11.26, p = .52. 
Examining the data reveals the authors use a log-transformation with base-10 of the case 
fatality ratio, and so the coefficients must be interpreted on this scale – that is, for a one-unit 
increase in national-level right-hand 2D:4D, log case fatality ratio increases by 51.84. It is 
more useful to cast this in terms of the actual case fatality ratio by applying an inverse log-10 
transformation, which yields the interpretation that a one-unit increase in national male right 
hand 2D:4D has a multiplicative effect on the case fatality ratio of 1051.84, which is an 
implausibly large effect. For example, the case fatality ratio of the United Kingdom in the 
data used by Manning and Fink (1) was 11.148, and the right hand 2D:4D ratio is 0.985. 
Applying this to a hypothetical individual (while ignoring the ecological fallacy) would 
suggest that a male with a right hand 2D:4D of half a standard deviation above average (an 
increase of 0.002 units, from 0.985 to 0.987), would have a mortality risk of 11.144 × 
(100.002*51.84) = 14.151%, or a relative increase in risk of 26.97%. This is similar to the 
differences in risk of cardiovascular disease when comparing men who have high blood 
pressure and high cholesterol or healthy levels of both (46). In short, according to the model 
of Manning and Fink (1), even a very small change in digit ratio should produce an 
implausibly large increase in mortality, which questions the credibility of their reported 
results. That these relationships hold over time unfortunately does not aid in their 
interpretation (2,3). 
 A Bayesian interpretation 
Taken together, the above points suggest that the hypothesis relating 2D:4D to 
COVID-19 outcomes has a weakening theoretical basis, makes individual-level conclusions 
from national-level data, and has problematic statistical inferences in terms of measures, 
corrections, and interpretability. Here, using Bayesian methods, we quantify the evidence for 
this hypothesis using data from Manning and Fink (3), re-examining their analysis of WHO 
Situation Report 165 (47). Given that, as of October 2020, COVID-19 is entering a ‘second 
wave’ globally (48), we also analyse data from the WHO Situation Report of 18th October 
(49) to examine whether the relationship exists.  
The Bayesian approach has a number of advantages for the current question. First, it 
answers the question policy makers and researchers are interested in, specifically what the 
probability of 2D:4D being associated with COVID-19 outcomes is given the available 
evidence. Current analytic approaches, based on frequentist statistics, only provide the 
reverse – the probability of observing the data given the hypothesis (50). Another advantage 
over frequentist estimation in this context is that Bayesian approaches are the only methods 
available for testing epistemic probability (51). Frequentist methods force researchers to 
assume infinite resamples of their data under identical conditions, which works well in 
experimental settings, but not for the current question – pandemics of the same disease are 
vanishingly rare, and the exact conditions under which they occur (global travel, healthcare 
systems, government responses, etc) vary dramatically. Bayesian methods are not constrained 
by this assumption, and thus can answer the question directly. Moreover, using a Bayesian 
approach also allows for the incorporation of prior belief into the analysis, allowing for the 
state of existing 2D:4D literature and theory to be taken into account. Given the need for 
robust evidence during the COVID-19 pandemic and the suboptimal quality of COVID-19 
research in other areas (44), a Bayesian interpretation can offer interested researchers or 
policy makers confidence that investing further in 2D:4D as a prognostic tool is a worthwhile 
endeavour, or whether the evidence is inconclusive. 
Study One – A reanalysis of Case Report 165 
Method 
Manning and Fink (3) report the analysis of WHO situation report 165 (3rd July, 
2020). As COVID-19 mortality has increased over time, the effects of the suggested 
relationships should be clearer with more deaths. The dataset contains 41 countries of which 
the number of cases and number of deaths are known, as well as measures of 2D:4D for both 
males and females and left and right hands (31). The national frequency of the ACE1 allele is 
known for 37 of those countries, and the frequency of the ACE2 genotype is known for 39. 
For each ACE variable, the countries with missing data were omitted when entered into an 
analysis with other variables. 
Manning and Fink (3) run several sets of analyses, but most prominent to their 
conclusions are two subsets: first, the correlations between national 2D:4D of female and 
male left and right hands, and ACE1/ACE2 frequency, and second, multiple regression 
models predicting log case fatality ratio from 2D:4D of female and male right and left hands, 
and the two ACE frequencies. The latter analyses are broken into separate models, such that 
log case fatality ratio is predicted from right hand male and female 2D:4D and ACE1, right 
hand male and female 2D:4D and ACE2, and so on. The versions of these analyses carried 
out using Bayesian inference are described below.  
Correlational analyses 
The same set of correlations (eight in total; correlating each variant of male and 
female, left and right digit ratio with both ACE polymorphism frequencies) were estimated 
using Bayesian methods. However, while frequentist approaches assume a uniform prior of 
correlation coefficients between -1 and 1, (that is, the probability of obtaining a correlation of 
-1 is identical to that of 0), a normal prior with mean zero and standard deviation of .25 was 
used here for the correlation coefficient. This reflects the belief that correlations between 2D: 
and ACE1 or ACE2 are more probable in the region of ±.25 (with 68% probability), and 
unlikely to be higher than ±.50. This is a crucial decision, that reflects that reflect the small-
to-medium effect sizes observed in meta-analytic studies of the association of 2D:4D with 
hormonal and androgen-linked traits, such as spatial navigation, aggression, and gender roles 
(16,52–54), whilst also incorporating the effect sizes seen between correlations of 2D:4D and 
cardiovascular and lung function (25,26,30). The flexibility of Bayesian analyses allows for 
these existing effect size estimates to be considered in the analysis of the current data. 
 In addition, a t-distributed likelihood was used, rather than a normal distribution. This 
provides a robust correlation – one that is not sensitive to outliers in the data, of which 
Pearson correlations are sensitive to, especially with small datasets (39,40). The t-distribution 
has heavier tails, which means that it is less affected by outliers or extreme data points in the 
data. Thus, this method allows for a fairer test of the hypothesis that national level 2D:4D is 
linked with ACE alleles and genotypes. It is worth noting explicitly that a t-distributed 
likelihood does not remove or ignore outliers in anyway; it simply considers as less extreme 
than does the standard assumption of normality. This property was the driving force behind 
the formulation of the distribution (55). 
Binomial Regression models 
Manning and Fink (1–3) use multiple regression models where log case fatality rate 
(the number of deaths divided by the number of cases) is predicted from various 
combinations of male, female, right and left 2D:4D, and ACE1 alleles and ACE2 genotype 
frequencies. As discussed above, this model formulation is difficult to interpret, and taking 
the ratio of number of reported cases and reported deaths is likely a biased estimate of the 
fatality risk of COVID-19 (35).  
The approach here is to build a binomial regression model that uses the data as it is 
provided, with no obfuscating transforms. Each nation has a given number of deaths, and a 
number of cases. The observed death count in a given nation can be thought of as a sample 
drawn from a binomial distribution, unique to that nation. A binomial distribution has two 
parameters – the number of events n and the probability of an event (i.e., a death from 
COVID-19) occurring, p. A linear model was built that directly predicted p using the logistic 
function on the predictors. Each nation was treated as its own separate binomial distribution 
by being assigned its own random intercept, allowing for generalisation to more nations than 
those observed. The fixed effect of male, female, and left and right 2D:4D, as well as ACE1 
and ACE2 was estimated across countries. The coefficients of this model can be interpreted 
in exactly the same way as those from a logistic regression, by exponentiating the 
coefficients. These can then be interpreted more in line with the WHO report, indicating the 
odds of being killed by COVID-19 on the sampled day, as the predictor increases by one 
standard deviation. Following Manning and Fink (3), four models were estimated, predicting 
p from male and female right 2D:4D and ACE1 prevalence, male and female right 2D:4D 
and ACE2 prevalence, and so on. 
Each model thus had three predictors – male and female 2D:4D, and ACE variant. For 
each coefficient, a normal prior was set with mean zero and a standard deviation of .30. 
These priors represent the belief about the magnitude of the coefficients in log-odds, and 
translate directly to the odds of being dead from COVID-19 at the time of sampling most 
likely between .74 and 1.35, with the probability of effects greater than that being small. That 
is, coefficients are estimated with prior knowledge that any effect associated with 2D:4D is 
likely to be small in magnitude (14,16), but also allowing for the larger effect sizes seen in 
studies testing relationships between 2D:4D and cardiovascular function (25,30). Priors for 
the intercept term (one per country) were normal with mean zero and standard deviation 1, 
allowing a weakly-informative prior on the baseline odds of p.  
Prior predictive checks. A common criticism of Bayesian analysis is that the choice 
of priors is subjective, or that the results of such an analysis are not an objective measure of 
probability, though there are clear rebuttals, including the main issue that likelihoods, and not 
priors, are typically the problem (56). In order to assuage these criticisms, we performed a 
prior predictive check (PrPC) on our models (57). A PrPC uses the prior specifications of the 
model, before it has seen the outcome data (that is, the number of deaths per country), to 
make a set of repeated predictions. If the model prior specification is sensible, then the model 
should be capable of producing datasets that approximate the observed data. We checked our 
prior specifications using a simple statistic – the total observed number of deaths. For case 
report 165, the total global deaths in the observed data was 451,373. By taking 1,000 sets of 
predictions from our prior models and computing the sum, we demonstrate that our prior 
specifications will consider outcomes much larger than what is observed, as shown in Figure 
1. For each model, the prior specification entertains global death counts as high as four 
million with relatively common frequency, though considers smaller death counts as more 
probable. Thus, our prior specification will not obfuscate or distort effects. 
 
Figure 1. Prior predictive checks for each model, illustrating the sum of deaths in each set of predictions. The 
actual death count observed in case report 165 is shown by the dashed line, which the prior specification 
predicts well. Much larger effects are also considered possible, and thus our priors are not restrictive.  
Bayesian decision-making 
As opposed to a single number yielded by a frequentist regression or correlation, a 
Bayesian analysis will return a posterior distribution of coefficients. This distribution reflects, 
given the data, the most probable values of the statistic of interest. These posterior 
distributions can be summarised in various ways to make decisions about hypotheses. The 
first approach taken here is to calculate the mean of the posterior, in addition to calculating 
the 95% highest density interval (HDI), or credible interval – the area of the posterior 
distribution that contains 95% of its values. The lower and upper bounds of the interval 
represent the values with which it is directly possible to assert, with 95% certainty, where the 
true value of the coefficient lies, based on the data (50). 
The HDI approach allows for an expression of (un)certainty around a statistic, which 
directly informs belief about the strength of evidence. A second approach used is that of the 
region of practical equivalence (ROPE; Kruschke, 2018; Makowski et al., 2019). A ROPE is 
a set of posterior values that can be considered to be null, in much the same way a point 
estimate of zero is used in null-hypothesis significance testing. For example, a region of -0.05 
to 0.05 for a regression coefficient might be considered a ROPE, as it contains zero and small 
effects that are of little practical or theoretical relevance. By defining a ROPE, it is possible 
to calculate the proportion of a posterior that falls within the ROPE and use that to inform 
decisions about a hypothesis. If a posterior distribution falls entirely within a ROPE, then the 
effect is practically null and can be discounted; if it falls entirely outside, then the null values 
can be fully rejected (58). If the posterior overlaps with the ROPE, the effect is inconclusive. 
Usefully, in that case, the percentage of the posterior in the ROPE can be used as a 
continuous measure of evidence of the lack of conclusiveness, as well as the direction (59). 
For example, if 90% of the posterior is in the ROPE then the evidence is inconclusive, but 
there is greater certainty that the effect is null. Conversely, if 10% of the posterior is in the 
ROPE, then the evidence is still inconclusive, but there is greater certainty the null values 
could be rejected with more data. This approach offers much more information than p-values.  
For the correlational analyses, a ROPE of between -.10 and .10 was used. This ROPE 
considers values surrounding zero, from -.10 to .10 as practically null, which is the threshold 
of a small effect size definition for correlations of ± .10 (60). For the binomial regression 
models, log-odds coefficients were exponentiated to the odds-ratio scale, and a ROPE of .95 
and 1.05 was used that corresponds to a region capturing a small reduction or increase in the 
odds of being killed by COVID-19 on the day of measurement. This ROPE corresponds to 
about half the magnitude of a small effect size for regression coefficients (50,58,60), and is 
thus a liberal ROPE (larger ROPEs being more conservative and difficult to overcome). 
Readers are welcome to define their own ROPE’s on the posterior distributions and can 
accept or reject parameter values they deem worthwhile.  
All analyses were estimated using Markov Chain Monte Carlo methods in PyMC3 
(61) and data and code are available on the Open Science Framework (osf.io/6v5u7).  
Results 
Correlation analysis 
The robust Bayesian correlations revealed weaker relationships between all national 
2D:4D measures and ACE alleles and genotypes than reported by Manning and Fink (3), 
though the negative direction of all of the correlations was preserved. While the full posterior 
distributions, reflecting the belief in the strength of the correlation coefficient, can be 
averaged to provide a single point estimate (which is consistently lower than those reported 
by Manning and Fink), the examination of the 95% credible intervals are illuminating. For 
each correlation, the credible interval contained zero and small positive values, and the ROPE 
fell directly within the interval, indicating an inconclusive result. The amount of the credible 
interval falling within the ROPE was also calculated, providing an estimate of how many 
values of the coefficient was practically null, ranging from approximately nine to 24 percent. 
Full posterior distributions are shown in Figure 2.  
 
Figure 2. The posterior distributions of each correlation coefficient, between male, female, left, and right 
2D:4D, and ACE I or II polymorphism prevalence. The solid vertical black line is the mean of the distribution 
(labelled), and the dashed grey vertical line is the frequentist correlation coefficient. The horizontal black line 
denotes the 95% credible interval, or the range of values that can be stated the true correlation lies in with 95% 
certainty. The small green bar represents the ROPE of -.10 to .10, which falls partially inside the posterior for all 
correlations, the proportion of which is displayed. 
Binomial regression models 
The probability of death in each country was predicted using a binomial regression 
model, using the different combinations of national male, female, left and right 2D:4D, as 
well as ACE1 allele and ACE2 genotype prevalence, deriving a set of posterior distributions 
for all coefficients. All these were estimated on the log-odds scale, and thus were 
exponentiated to express them as odds ratios. Odds above one indicated a higher likelihood of 
being killed from COVID-19 on the sampled data. The full posterior distributions are shown 
in Figure 3. 
 
Figure 3. Coefficients of binomial regressions for the different combinations of model specifications. Each 
posterior represents the odds ratio of being killed by COVID-19 on the date sampled, from a one standard-
deviation increase in the predictor. Means represent the average of the posterior, and the solid black lines the 
95% credible intervals or highest posterior density. The small green bar represents the ROPE of 0.95 to 1.05. 
These posteriors represent the belief of how much, given the data, COVID-19 deaths 
in each country will change given a one-standard-deviation change in the predictor. Across 
all models and coefficients, the credible intervals were generally wide, with estimates of odds 
being above and below one, indicating that whether deaths will go up or down with the 
predictor cannot be expressed with at least 95% confidence. In all coefficients, the posterior 
overlapped with the ROPE, and in some cases substantially so. In two cases, for male left 
hand 2D:4D, did the proportions fall below 5%. While the means of the distributions indicate 
the central tendency of the direction of the effect here (i.e., that it is a positive effect), the 
posterior overlaps with the ROPE, and the credible interval begins with a null effect (i.e., an 
odds of one). 
The models can be used to make predictions that incorporate uncertainty to 
demonstrate the usefulness of the inferences that can be made with the data. As an example, 
consider the left hand 2D:4D model with ACE2 genotype frequency (which has the largest 
coefficient estimates), and the predictions for the United Kingdom. The observed number of 
deaths for the UK was 43,995 out of 283,761 cases. Holding constant female 2D:4D and 
ACE2 genotype frequency, and assuming an increase in the UK’s male 2D:4D of 0.02 units 
(equivalent to half a standard deviation in global male left 2D:4D, from 0.986 to 0.988), leads 
to a predicted death count of 43,553, but with a lower 95% credible interval of 33,145, and an 
upper interval of 57,175. That is, predicted deaths might decrease by 25%, or increase by 
30%. This illustrates the poor informativeness of 2D:4~D as a predictor of COVID-19 
mortality – these are very wide margins when measured in human lives.  
Study 2 – Case Report as of 18th October 2020 
 The above reanalysis of the data presented by Manning and Fink (3) suggests that the 
effects of 2D:4D and ACE on COVID-19 outcomes are generally inconclusive, aside from 
somewhat uncertain effects of male left-hand 2D:4D that seem to be positive, though one 
cannot exclude no effect. However, Manning and Fink (2,3) show statistically significant 
effects at multiple time points, though these come with substantial caveats as described 
above. As COVID-19 is now entering a second wave (48), it is possible that nations with the 
hypothesized relationships suggested by Manning and Fink (3) – i.e., positive relationships 
between male 2D:4D and COVID-19 outcomes, and negative relationships between 2D:4D 
and ACE1 and ACE2 frequencies. Here, we analyse the case report given by the WHO on 
October 18th, repeating the same binomial regressions as above with the updated case and 
death data. 
Results 
 The posteriors for the October data report are shown in Figure 4. In this more recent 
data, during the second wave, there are again no conclusive effects. For all coefficients, the 
95% credible interval contained one, or no effect, and the lowest overlap with the ROPE was 
5.59%, and the effects of left hand male 2D:4D are weaker.  
Figure 4. Coefficients of binomial regressions for the different combinations of model specifications, for 
October 2020 data. Each posterior represents the odds ratio of being killed by COVID-19 on the date sampled, 
from a one standard-deviation increase in the predictor. Means represent the average of the posterior, and the 
solid black lines the 95% credible intervals or highest posterior density. The small green bar represents the 
ROPE of 0.95 to 1.05. 
General Discussion 
 The hypothesis that COVID-19 outcomes are associated with national level 2D:4D, as 
well as ACE1 allele and ACE2 genotype frequency has been tested critically here using 
updated data and Bayesian methods, which offer a series of advantages. Manning and Fink 
(1–3) suggest that nations with higher male 2D:4D have higher case fatality ratios, and infer 
this result is due to a host of genetic and hormonal processes influence the relationships 
between 2D:4D and bodily reactions to COVID-19 infection.  
We first tested the relationship between national 2D:4D and ACE frequencies using 
robust correlations that are not sensitive to outliers (62). The mean of the posterior 
distributions of these tests, which can be taken as a point-estimate of the correlation in the 
same way as a frequentist estimate, are all negative, and in some cases around half the size of 
the original estimate reported by Manning and Fink (3). This indicates that the original 
estimates are affected by outliers. Second, in all but one correlation, the 95% credible interval 
contains positive values. That is, given this data, asserting 95% confidence in the correlation 
estimate implies being forced to consider a positive effect, counter to the original hypothesis 
of Manning and Fink. To be certain of only a negative effect would mean reducing the 
credible interval, which is a difficult stance to reconcile with evidence that can aid a global 
pandemic. Finally, the amount of posterior in the ROPE varied from moderate to relatively 
small; suggesting that, for some effects, a decision about the presence of an effect was close. 
However, the most conservative conclusion is that the results are inconclusive for national-
level associations between 2D:4D and ACE1 allele frequency or ACE2 genotype frequency. 
The binomial regressions on the case report 165 data showed similar outcomes, 
providing no conclusive evidence of an effect of any of the predictors, under any combination 
of hand, sex, or ACE frequencies. Manning and Fink and Sahin (1–3,45) suggest that higher 
male 2D:4D has a positive relationship with COVID-19 fatality, as well as a negative 
association for females. The posterior distributions of the regression coefficients, expressed 
as odds, showed no conclusive evidence of these effects, though the general direction of the 
effects were preserved. However, the credible intervals included null (that is, an odds of one) 
or possible values in the opposite direction. For some coefficients, overlap in the posterior 
with the ROPE was small, indicating less uncertainty the absence of an effect. However, 
there is no conclusive evidence of an association between 2D:4D and COVID-19 mortality at 
that time point. 
As the WHO provides continual updates of the COVID-19 pandemic, any 
relationships that may exist between 2D:4D and COVID-19 outcomes should become 
stronger over time as the outcome variable is estimated with greater precision. This is 
particularly true as COVID-19 enters its second wave – nations with greater male 2D:4D and 
lower ACE frequencies should see more deaths out of their reported cases, given the 
hypothesis. Repeating our analysis for the most recent data at the time of writing yielded the 
same conclusions as case report 165, with the posterior distributions of all coefficients 
overlapping with negative or null effects. Thus, the posterior distributions convey how much 
belief we should allocate to the hypothesis, which is that it is inconclusive given the existing 
data. 
The role of scientific research in understanding and treating COVID-19 is paramount. 
The hypotheses proposed by Manning and Fink (1–3) combine existing evidence around 
testosterone exposure (as indexed by 2D:4D) and COVID-19 outcomes, which offers a 
potentially useful clinical measure of susceptibility to the disease. Though this hypothesis is 
well grounded in biological theory, the current data do not speak to it clearly, particularly 
because national-level datasets do not necessarily offer insight into individual level outcomes 
(33), and the current analyses are not easily interpretable. By using Bayesian methods, the 
current analyses are robust, allow for the incorporation of prior information, and provide 
clean interpretations of the relationships that are currently obfuscated, and further add to 
criticism of the hypothesis (Jones et al., 2020). Our simple claim here is that, conditional on 
the existing data, there is no clear evidence of the hypothesis being supported. While 
Manning and Fink rightly urge for individual level data to corroborate these findings (1–3), 
these are likely to be costly and would come with serious ethical implications, and with the 
existing national level data, we see no clear evidence to pursue these research questions.  
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